Feng Chi Biotech Corp. (6744.TWO)

TWD 19.7

(0.0%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 180.57 Million 193.46 Million 182.57 Million 178.9 Million 174.32 Million
Cost of Revenue 99.85 Million 110.01 Million 96.46 Million 92.98 Million 102.08 Million
Gross Profit 80.72 Million 83.44 Million 86.1 Million 85.92 Million 72.24 Million
Operating Expenses 49.47 Million 56.37 Million 59.66 Million 57.34 Million 52.56 Million
Selling, General and Administrative Expenses 36.37 Million 44.28 Million 45.47 Million 45.43 Million 39.2 Million
Research and Development Expenses 13.09 Million 12.09 Million 14.18 Million 11.9 Million 12.94 Million
Other Expenses - 1.53 Million 337 Thousand -435 Thousand -
Cost and Expenses 156.41 Million 166.39 Million 156.12 Million 150.32 Million 154.64 Million
Operating Income 24.16 Million 30.47 Million 28.15 Million 29.99 Million 20.09 Million
Interest Expense 325 Thousand 58 Thousand 98 Thousand 167 Thousand 17 Thousand
Income Tax Expense 4.5 Million 5.8 Million 4.92 Million 4.43 Million 4.33 Million
Earnings before Tax 27.29 Million 30.41 Million 28.05 Million 29.82 Million 21.69 Million
Net Income 22.79 Million 24.61 Million 23.13 Million 25.39 Million 17.35 Million
Earnings Per Share Basic 1.48 1.60 1.50 1.65 1.16
Earnings Per Share Diluted 1.47 1.60 1.50 1.64 1.16
Weighted Average Shares Outstanding 15.4 Million 15.38 Million 15.4 Million 15.4 Million 14.95 Million
Weighted Average Shares Outstanding (Diluted) 15.45 Million 15.38 Million 15.45 Million 15.45 Million 14.98 Million
Gross Margin 0.45 0.43 0.47 0.48 0.41
EBIT Margin 0.19 0.19 0.20 0.22 0.16
Profit Margin 0.13 0.13 0.13 0.14 0.10
EBITDA 34.83 Million 36.78 Million 36.95 Million 39.88 Million 27.58 Million
Earnings Before Tax Margin 0.13 0.16 0.15 0.17 0.12

Income Statement Charts